🎯 Other
Will the FDA approve retatrutide?

Will the FDA approve retatrutide? — Before Jan 1, 2029

Live
Resolves Jan 1, 2029Kalshi
Volume-weighted avg
92%
No
8%
No (8%)Yes (92%)
Probability History
Loading...
Market snapshot
Status
Open
Category
Other
Vol 24h
—
Liquidity
$82

Market intelligence

Kalshi currently prices this at 92%.

About this market

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2029, then the market resolves to Yes.

All outcomes · Will the FDA approve retatrutide?

Trade this marketLive prices
Avg probability
92%
probability of YES
Kalshi
TGWA
Resolution
Jan 1, 2029
Market is open
Market stats
24h volume—
Liquidity$82
CategoryOther
StatusOpen